Skip to main content
SpringerLink
Log in

Preventative strategies may reduce the risk of chronic kidney disease in elderly patients receiving lithium

  • Drug Reactions and Interactions
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Although lithium is an effective treatment of various mood disorders, including those in elderly patients, it is often underutilized out of fear of its adverse effects. Current evidence does not support a conclusive link between lithium treatment and chronic kidney disease (CKD) in elderly patients, especially those with normal pre-morbid renal function. The appropriate use of preventative strategies may help prevent CKD and further renal decline in elderly patients receiving lithium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Rej S, Elie D, Mucsi I, et al. Chronic kidney disease in lithium-treated older adults: a review of epidemiology, mechanisms, and implications for the treatment of late-life mood disorders. Drugs Aging. 2015;32(1):31–42.

    Article  CAS  PubMed  Google Scholar 

  2. Grof P. Sixty years of lithium responders. Neuropsychobiology. 2010;62(1):8–16.

    Article  CAS  PubMed  Google Scholar 

  3. Shulman KI, Rochon P, Sykora K, et al. Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence. BMJ. 2003;326(7396):960.

    Article  PubMed Central  PubMed  Google Scholar 

  4. National quality use of medicines indicators for Australian hospitals. Sydney: Australian Commission on Safety and Quality in Health Care and NSW Therapeutic Advisory Group Inc.; 2014.

  5. Crowe E, Halpin D, Stevens P. Early identification and management of chronic kidney disease: summary of NICE guidance. Guideline Development Group. BMJ. 2008;2008(337):a1530.

    Article  Google Scholar 

  6. Rej S, Looper K, Segal M. The effect of serum lithium levels on renal function in geriatric outpatients: a retrospective longitudinal study. Drugs Aging. 2013;30(6):409–15.

    Article  CAS  PubMed  Google Scholar 

  7. van Melick EJ, Meinders AE, Hoffman TO, et al. Renal effects of long-term lithium therapy in the elderly: a cross-sectional study. Int J Geriatr Psychiatry. 2008;23(7):685–92.

    Article  PubMed  Google Scholar 

  8. Rej S, Shulman K, Herrmann N, et al. Prevalence and correlates of renal disease in older lithium users: a population-based study. Am J Geriatr Psychiatry. 2014;22(11):1075–82.

    Article  PubMed  Google Scholar 

  9. Rej S, Abitbol R, Looper K, et al. Chronic renal failure in lithium-using geriatric patients: effects of lithium continuation versus discontinuation—a 60-month retrospective study. Int J Geriatr Psychiatry. 2013;28(5):450–3.

    Article  PubMed  Google Scholar 

  10. Close H, Reilly J, Mason JM, et al. Renal failure in lithium-treated bipolar disorder: a retrospective cohort study. PLoS One. 2014;9(3):e90169.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038–47.

    Article  CAS  PubMed  Google Scholar 

  12. Andreazza AC, Gildengers A, Rajji TK, et al. Oxidative stress in older patients with bipolar disorder. Am J Geriatr Psychiatry. 2015;23(3):314–9.

    Article  PubMed  Google Scholar 

  13. Aiff H, Attman PO, Aurell M, et al. End-stage renal disease associated with prophylactic lithium treatment. Eur Neuropsychopharmacol. 2014;24(4):540–4.

    Article  CAS  PubMed  Google Scholar 

  14. Aiff H, Attman PO, Aurell M, et al. The impact of modern treatment principles may have eliminated lithium-induced renal failure. J Psychopharmacol. 2013;28(2):151–4.

    Article  PubMed  Google Scholar 

  15. Rej S, Li BW, Looper K, et al. Renal function in geriatric psychiatry patients compared to non-psychiatric older adults: effects of lithium use and other factors. Aging Ment Health. 2014;18(7):847–53.

    Article  PubMed  Google Scholar 

  16. Aprahamian I, Santos FS, dos Santos B, et al. Long-term, low-dose lithium treatment does not impair renal function in the elderly: a 2-year randomized, placebo-controlled trial followed by single-blind extension. J Clin Psychiatry. 2014;75(7):e672–8.

    Article  CAS  PubMed  Google Scholar 

  17. Hardy BG, Shulman KI, Zucchero C. Gradual discontinuation of lithium augmentation in elderly patients with unipolar depression. J Clin Psychopharmacol. 1997;17(1):22–6.

    Article  CAS  PubMed  Google Scholar 

  18. Head L, Dening T. Lithium in the over-65 s: who is taking it and who is monitoring it? A survey of older adults on lithium in the Cambridge Mental Health Services catchment area. Int J Geriatr Psychiatry. 1998;13(3):164–71.

    Article  CAS  PubMed  Google Scholar 

  19. Tredget J, Kirov A, Kirov G. Effects of chronic lithium treatment on renal function. J Affect Disord. 2010;126(3):436–40.

    Article  CAS  PubMed  Google Scholar 

  20. Bendz H, Schön S, Attman PO, et al. Renal failure occurs in chronic lithium treatment but is uncommon. Kidney Int. 2010;77:219–24.

    Article  CAS  PubMed  Google Scholar 

  21. Collins N, Barnes TR, Shingleton-Smith A, et al. Standards of lithium monitoring in mental health trusts in the UK. BMC Psychiatry. 2010;10:80.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Ng F, Mammen OK, Wilting I, et al. The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Biopolar Disord. 2009;11(6):559–95.

    Article  CAS  Google Scholar 

  23. Hardy BG, Shulman KI, Mackenzie SE, et al. Pharmacokinetics of lithium in the elderly. J Clin Psychopharmacol. 1987;7(3):153–8.

    Article  CAS  PubMed  Google Scholar 

  24. Oakley PW, Whyte IM, Carter GL. Lithium toxicity: an iatrogenic problem in susceptible individuals. Aust N Z J Psychiatry. 2001;35(6):833–40.

    Article  CAS  PubMed  Google Scholar 

  25. van Melick EJ, Souverein PC, den Breeijen JH, et al. Age as a determinant of instability of serum lithium concentrations. Ther Drug Monit. 2013;35(5):643–8.

    PubMed  Google Scholar 

  26. Juurlink DN, Mamdani MM, Kopp A, et al. Drug-induced lithium toxicity in the elderly: a population-based study. J Am Geriatr Soc. 2004;52(5):734–8.

    Google Scholar 

  27. Vestergaard P, Amdisen A, Hansen HE, et al. Lithium treatment and kidney function. A survey of 237 patients in long-term treatment. Acta Psychiatr Scand. 1979;60(5):504–20.

    Article  CAS  PubMed  Google Scholar 

  28. Weinstein JR, Anderson S. The aging kidney: physiological changes. Adv Chronic Kidney Dis. 2010;17(4):302–7.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Kilbourne AM, Goodrich DE, Lai Z, et al. Randomized controlled trial to assess reduction of cardiovascular disease risk in patients with bipolar disorder: the Self-Management Addressing Heart Risk Trial (SMAHRT). J Clin Psychiatry. 2013;74(7):e655–62.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Bedford JJ, Weggery S, Ellis G, et al. Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride. Clin J Am Soc Nephrol. 2008;3(5):1324–31.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  31. Ghannoum M, Lavergne V, Yue CS, et al. Successful treatment of lithium toxicity with sodium polystyrene sulfonate: a retrospective cohort study. Clin Toxicol (Phila). 2010;48(1):34–41.

    Article  CAS  Google Scholar 

  32. Trepiccione F, Christensen BM. Lithium-induced nephrogenic diabetes insipidus: new clinical and experimental findings. J Nephrol. 2010;23(Suppl 16):S43–8.

    PubMed  Google Scholar 

  33. Chen CH, Lee CS, Lee MT, et al. Variant GADL1 and response to lithium therapy in bipolar I disorder. N Engl J Med. 2014;370(2):119–28.

    Article  CAS  PubMed  Google Scholar 

  34. Werneke U, Ott M, Salander Renberg E, et al. A decision analysis of long-term lithium treatment and the risk of renal failure. Acta Psychiatr Scand. 2012;126(3):186–97.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

    Consortia

    Adis Medical Writers

    Ethics declarations

    The article was adapted from Drugs & Aging 2015;32(1):31–42 [1] by salaried/contracted employees of Adis/Springer and was not supported by any external funding.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Adis Medical Writers. Preventative strategies may reduce the risk of chronic kidney disease in elderly patients receiving lithium. Drugs Ther Perspect 31, 443–447 (2015). https://doi.org/10.1007/s40267-015-0250-9

    Download citation

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s40267-015-0250-9

    Keywords

    Search

    Navigation